Search Results

Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy.

• Authors : Song, Chi Hun¹ (AUTHOR) ; Jeong, Minchan¹ (AUTHOR) ; In, Hyukmin¹ (AUTHOR)

Subjects: *ANTIBODY-drug conjugates; *CANCER cell growth; *CANCER treatment

• Source: Antibodies (2073-4468). Dec2023, Vol. 12 Issue 4, p72. 22p.

Record details

Evaluation of Two Chemoenzymatic Glycan Remodeling Approaches to Generate Site-Specific Antibody–Drug Conjugates.

• Authors : Yang, Qiang¹ (AUTHOR) ; Chen, He¹ (AUTHOR); Ou, Chong² (AUTHOR)

Subjects: *ANTIBODY-drug conjugates; *WEIGHT loss; *OXAZOLINE

• Source: Antibodies (2073-4468). Dec2023, Vol. 12 Issue 4, p71. 14p.

Record details

Antibody-Drug Conjugates for the Treatment of Non-Small Cell Lung Cancer with Central Nervous System Metastases.

• Authors : Bian DJH; Department of Internal Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 1G1, Canada.; Cohen SF

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Immunoconjugates*/Immunoconjugates*/Immunoconjugates*/therapeutic use ; Immunoconjugates*/Immunoconjugates*/Immunoconjugates*/pharmacology

• Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Oct 18; Vol. 31 (10), pp. 6314-6342. Date of Electronic Publication: 2024 Oct 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet

Record details

Targeted Therapy in Breast Cancer: Advantages and Advancements of Antibody-Drug Conjugates, a Type of Chemo-Biologic Hybrid Drugs.

• Authors : Mukherjee A; School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Patia, Bhubaneswar 751024, Odisha, India.; Bandyopadhyay D

• Source: Cancers [Cancers (Basel)] 2024 Oct 17; Vol. 16 (20). Date of Electronic Publication: 2024 Oct 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print

Record details

Antibody-Drug Conjugates and Their Potential in the Treatment of Patients with Biliary Tract Cancer.

• Authors : Alexander S; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK.; Aleem U

• Source: Cancers [Cancers (Basel)] 2024 Sep 30; Vol. 16 (19). Date of Electronic Publication: 2024 Sep 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print

Record details

Antibody-Drug Conjugates to Promote Immune Surveillance: Lessons Learned from Breast Cancer.

• Authors : Nucera, Sabrina; Conti, Chiara; Martorana, Federica

Subjects: IMMUNE checkpoint inhibitors; ANTIBODY-drug conjugates; THERAPEUTICS

• Source: Biomedicines; Jul2024, Vol. 13 Issue 7, p1491, 16p

Record details

Synergizing Immunotherapy and Antibody-Drug Conjugates: New Horizons in Breast Cancer Therapy.

• Authors : Pinto A; Oncology Unit, 'Dario Camberlingo' Hospital, 72021 Francavilla Fontana, Italy.; Guarini C

• Source: Pharmaceutics [Pharmaceutics] 2024 Aug 29; Vol. 16 (9). Date of Electronic Publication: 2024 Aug 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print

Record details

Antibody Drug Conjugates for Cancer Therapy: From Metallodrugs to Nature-Inspired Payloads.

• Authors : Tonon G; Department of Molecular Sciences and Nanosystems, Università Ca' Foscari Campus Scientifico, Via Torino 155, 30174 Venezia-Mestre, Italy.; Rizzolio F

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Immunoconjugates*/Immunoconjugates*/Immunoconjugates*/chemistry ; Immunoconjugates*/Immunoconjugates*/Immunoconjugates*/therapeutic use

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 08; Vol. 25 (16). Date of Electronic Publication: 2024 Aug 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer.

• Authors : Sato S; Department of Obstetrics and Gynecology, Iwate Medical University, Yahaba 028-3694, Iwate, Japan.; Shoji T

• Source: Cancers [Cancers (Basel)] 2024 Jul 15; Vol. 16 (14). Date of Electronic Publication: 2024 Jul 15.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print

Record details

The Evolving Paradigm of Antibody-Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases.

• Authors : High P; Center for Translational Cancer Research, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and UTHealth Houston, Houston, TX 77030, USA.

• Source: Pharmaceutics [Pharmaceutics] 2024 Jul 02; Vol. 16 (7). Date of Electronic Publication: 2024 Jul 02.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print

Record details